{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:01:52Z","timestamp":1785250912796,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006022","name":"French Government Ministry of Social Affairs Health and Womens Rights","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vaccine.2026.128732","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:55:16Z","timestamp":1779414916000},"page":"128732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunological efficacy and safety of influenza vaccination in adults with sarcoidosis: the SARCOVAC study"],"prefix":"10.1016","volume":"86","author":[{"given":"Brigitte","family":"Ranque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Galtier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilario","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Le Jeunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gw\u00e9na\u00eblle","family":"Roguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Isra\u00ebl-Biet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beny","family":"Charbit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Deplanque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eblle","family":"Detoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dual\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Meritet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendy","family":"Abdoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Brauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guilpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128732_bb0005","unstructured":"Centers for Disease Control and Prevention. Disease burden of flu. https:\/\/www.cdc.gov\/flu\/about\/burden\/index.html. Accessed 12 August 2024."},{"key":"10.1016\/j.vaccine.2026.128732_bb0010","unstructured":"World Health Organization. Global influenza programme. Burden of disease. https:\/\/www.who.int\/teams\/global-influenza-programme\/surveillance-and-monitoring\/burden-of-disease. Accessed 12 August 2024."},{"issue":"3","key":"10.1016\/j.vaccine.2026.128732_bb0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128732_bb0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","article-title":"Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses","volume":"9","author":"Kunisaki","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128732_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"Seve","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128732_bb0030","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02419-2016","article-title":"Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris","volume":"50","author":"Duchemann","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.vaccine.2026.128732_bb0035","doi-asserted-by":"crossref","unstructured":"Jamilloux Y, Maucort-Boulch D, Kerever S, et al. Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis. Eur Respir J 2016;48(6):1700\u20139. doi:10.183\/13993003.00457-2016. [Epub 2016 Sep 22].","DOI":"10.1183\/13993003.00457-2016"},{"key":"10.1016\/j.vaccine.2026.128732_bb0040","doi-asserted-by":"crossref","unstructured":"Rossides M, Kullberg S, Askling J, Eklund A, Grunewald J, Arkema EV. Sarcoidosis mortality in Sweden: a population-based cohort study. Eur Respir J 2018;51(2):1701815. doi:10.1183\/13993003.01815-2017. Print 2018 Feb.","DOI":"10.1183\/13993003.01815-2017"},{"key":"10.1016\/j.vaccine.2026.128732_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.vaccine.2026.128732_bb0050","doi-asserted-by":"crossref","unstructured":"Baughman RP, Valeyre D, Korsten P, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J 2021;58(6):2004079. doi:10.1183\/13993003.04079-2020. Print 2021 Dec.","DOI":"10.1183\/13993003.04079-2020"},{"key":"10.1016\/j.vaccine.2026.128732_bb0055","doi-asserted-by":"crossref","unstructured":"Tavana S, Argani H, Gholamin S, et al. Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety. Influenza Other Respi Viruses 2012;6(2):136\u201341.","DOI":"10.1111\/j.1750-2659.2011.00290.x"},{"key":"10.1016\/j.vaccine.2026.128732_bb0060","doi-asserted-by":"crossref","unstructured":"Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of directors and by the ERS executive committee, February 1999. Am J Respir Crit Care Med 1999;160(2):736\u201355. doi:https:\/\/doi.org\/10.1164\/ajrccm.160.2.ats4-99.","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128732_bb0065","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1164\/rccm.200705-742OC","article-title":"Phenotyping sarcoidosis from a pulmonary perspective","volume":"177","author":"Prasse","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2026.128732_bb0070","doi-asserted-by":"crossref","unstructured":"Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J 1961;2(5261):1165\u201372. doi:10.36\/bmj.2.5261.1165.","DOI":"10.1136\/bmj.2.5261.1165"},{"key":"10.1016\/j.vaccine.2026.128732_bb0075","series-title":"Concepts and procedures for laboratory-based influenza surveillance","author":"Kendal","year":"1982"},{"key":"10.1016\/j.vaccine.2026.128732_bb0080","unstructured":"Center for Biologics Evaluation and Research. Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials - Guidance for Industry. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/toxicity-grading-scale-healthy-adult-and-adolescent-volunteers-enrolled-preventive-vaccine-clinical. Accessed 05 dec 2024."},{"issue":"2","key":"10.1016\/j.vaccine.2026.128732_bb0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/vaccines10020303","article-title":"The effect of smoking on humoral response to COVID-19 vaccines: a systematic review of epidemiological studies","volume":"10","author":"Ferrara","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128732_bb0090","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/QAI.0b013e318183a9c0","article-title":"Immunological efficacy of a three-dose schedule of hepatitis a vaccine in HIV-infected adults: HEPAVAC study","volume":"49","author":"Launay","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128732_bb0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/irv.12351","article-title":"A review of the changes to the licensing of influenza vaccines in Europe","volume":"10","author":"Wijnans","year":"2016","journal-title":"Influenza Other Respi Viruses"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128732_bb0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.crohns.2012.05.011","article-title":"Immune response to influenza a\/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-alpha agents: effects of combined therapy with immunosuppressants","volume":"7","author":"Andrisani","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.vaccine.2026.128732_bb0105","doi-asserted-by":"crossref","unstructured":"deBruyn JC, Hilsden R, Fonseca K, et al. Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease. Inflamm Bowel Dis 2012;18(1):25\u201333.","DOI":"10.1002\/ibd.21706"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128732_bb0110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2008.120","article-title":"Immune response to influenza vaccine in children with inflammatory bowel disease","volume":"104","author":"Lu","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128732_bb0115","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cgh.2007.02.035","article-title":"Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease","volume":"5","author":"Mamula","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2026.128732_bb0120","article-title":"Immunization against influenza during the 2005\/2006 epidemic season and the humoral response in children with diagnosed inflammatory bowel disease (IBD)","volume":"16(9):CR433-9","author":"Romanowska","year":"2010","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.vaccine.2026.128732_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103247","article-title":"The immunopathogenesis of sarcoidosis","volume":"149","author":"Miedema","year":"2024","journal-title":"J Autoimmun."},{"issue":"8","key":"10.1016\/j.vaccine.2026.128732_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043588","article-title":"Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels","volume":"7","author":"Saussine","year":"2012","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128732_bb0135","first-page":"72","article-title":"Serum B cell activating factor (BAFF) and sarcoidosis activity","volume":"36","author":"Hashemzadeh","year":"2020","journal-title":"Arch Rheumatol."},{"issue":"3","key":"10.1016\/j.vaccine.2026.128732_bb0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.amjmed.2021.08.038","article-title":"Influenza vaccination in systemic lupus erythematosus: efficacy, effectiveness, safety, utilization, and barriers","volume":"135","author":"Sim","year":"2022","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128732_bb0145","article-title":"A review of the efficacy of influenza vaccination in autoimmune disease patients","volume":"13","author":"Abdelahad","year":"2021","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128732_bb0150","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.vaccine.2019.01.007","article-title":"A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis","volume":"37","author":"Strijbos","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128732_bb0155","doi-asserted-by":"crossref","unstructured":"Launay O, Abitbol V, Krivine A, et al. Immunogenicity and safety of influenza vaccine in inflammatory bowel disease patients treated or not with immunomodulators and\/or biologics: a two-year prospective study. J Crohns Colitis 2015;9(12):1096\u2013107. doi:10.3\/ecco-jcc\/jjv152. [Epub 2015 Sep 7].","DOI":"10.1093\/ecco-jcc\/jjv152"},{"key":"10.1016\/j.vaccine.2026.128732_bb0160","doi-asserted-by":"crossref","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, M\u00fcller-Quernheim J. Sarcoidosis. Lancet 2014;383(9923):1155\u201367. doi:10.016\/S0140-6736(13)60680-7. [Epub 2013 Oct 1].","DOI":"10.1016\/S0140-6736(13)60680-7"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128732_bb0165","doi-asserted-by":"crossref","first-page":"260","DOI":"10.7326\/0003-4819-40-2-260","article-title":"Altered immunologic reactions in sarcoidosis","volume":"40","author":"Sones","year":"1954","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128732_bb0170","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3181\/00379727-121-30851","article-title":"Serum antibody response in sarcoidosis","volume":"121","author":"Persellin","year":"1966","journal-title":"Proc Soc Exp Biol Med"},{"issue":"5084","key":"10.1016\/j.vaccine.2026.128732_bb0175","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1136\/bmj.1.5084.1388","article-title":"Circulating antibodies in sarcoidosis","volume":"1","author":"Greenwood","year":"1958","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2026.128732_bb0180","unstructured":"Seyhan EC, Gunluoglu G, Altin S, et al. Results of tetanus vaccination in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2012;29(1):3\u201310."},{"issue":"5","key":"10.1016\/j.vaccine.2026.128732_bb0185","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1159\/000067471","article-title":"Results of hepatitis B vaccination in sarcoidosis","volume":"67","author":"Mert","year":"2000","journal-title":"Respiration"},{"key":"10.1016\/j.vaccine.2026.128732_bb0190","doi-asserted-by":"crossref","unstructured":"Atahan E, \u00c7al\u0131\u015fkaner \u00d6zt\u00fcrk B, Ak\u00e7in R, Sar\u0131ba\u015f S, Kocazeybek B. Humoral and cellular immunity to severe acute respiratory syndrome Coronavirus-2 vaccination in patients with sarcoidosis. Balkan Med J 2023;40(1):34\u20139. doi:10.4274\/balkanmedj.galenos.2022.-8-64. [Epub Dec 9].","DOI":"10.4274\/balkanmedj.galenos.2022.2022-8-64"},{"key":"10.1016\/j.vaccine.2026.128732_bb0195","unstructured":"Vagts C, Sweis JJG, Sweis NWG, et al. Initial behaviors and attitudes towards the COVID-19 vaccine in sarcoidosis patients: results of a self-reporting questionnaire. Sarcoidosis Vasc Diffuse Lung Dis 2023;40(2):e2023012. doi:10.36141\/svdld.v40i2.14388."},{"key":"10.1016\/j.vaccine.2026.128732_bb0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:38:57Z","timestamp":1785249537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S0264410X26005414"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128732","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological efficacy and safety of influenza vaccination in adults with sarcoidosis: the SARCOVAC study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128732"}}